From Wikipedia, the free encyclopedia
Jump to: navigation, search
Defunct 14 October 2013[1]
Headquarters Huntingdon, United Kingdom
Area served

Phytopharm is a pharmaceutical company based in the United Kingdom. According to the company's website, Phytopharm's lead products are Cogane and Myogane, which are members of the sapogenin class of compounds. It is listed on the London Stock Exchange and is a constituent of the FTSE Fledgling Index.[citation needed]

Company collapsed following failure of its main drug during clinical trials.[2]


  1. ^ "Phytopharm shareholders approve IXICO acquisition". 14 October 2013. Retrieved 9 December 2014. 
  2. ^ "Phytopharm says Cogane Phase II trials disappoint". 18 February 2013. Retrieved 9 December 2014. 

See also[edit]

External links[edit]